» Articles » PMID: 36001272

Computed Tomography-based Paravertebral Muscle Density Predicts Subsequent Vertebral Fracture Risks Independently of Bone Mineral Density in Postmenopausal Women Following Percutaneous Vertebral Augmentation

Overview
Publisher Springer
Specialty Geriatrics
Date 2022 Aug 24
PMID 36001272
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The risk of subsequent vertebral fractures (SVF) after the primary vertebral fracture cannot be explained by lower bone mineral density (BMD) alone. Computed tomography (CT) measurements of paravertebral muscle density (PMD) are recognized radiographic markers used to predict physical function, fragile fractures.

Aims: This study aims to investigate the relationship between PMD and the risk of SVF in cohorts of postmenopausal women, and to determine if combining both PMD and BMD measures derived from CT can improve the accuracy of predicting SVF.

Methods: This study enrolled 305 postmenopausal women between the ages of 50 and 88 for 3 years of follow-up studies. Trabecular attenuation (Hounsfield units, HU) was measured at L1 level and muscle attenuation of paravertebral muscle at L3 level on preoperative lumbar CT scans to determine the L1 BMD and L3 PMD. Kaplan-Meier analysis was applied to evaluate SVF-free survival. The hazard ratios (HRs) of PMD for SVF events were estimated with the Cox proportional hazards model. The predictive values of L1 BMD and L3 PMD for SVF were quantified using the Receiver-Operating Characteristic (ROC) curve.

Result: During the 3 years of follow-up studies, 88 patients (28.9%) suffered an SVF. ROC curve analysis demonstrated that an L3 PMD threshold of 32 HU had a sensitivity of 89.8% and a specificity of 62% for the prediction of SVF. Kaplan-Meier analysis showed that L3 PMD ≤ 32 HU was significantly associated with lower SVF-free survival (p < 0.001; log-rank test). After adjusting for age, BMI, diabetes, postoperative osteoporosis treatment, handgrip strength, L1 BMD, multivariate analyses also indicated a persistent modest effect of L3 PMD on SVF-free survival. The area under the ROC curve of L3 PMD and L1 BMD, combined to predict the risk of SVF, was 0.790, which was significantly higher than the value for L1 BMD alone (0.735). L3 PMD and L1 BMD significantly improved the accuracy of SVF risk prediction compared with L1 BMD alone, which was confirmed by reclassification improvement measures. The inclusion of handgrip strength and postoperative osteoporosis treatment in the model further improved SVF prediction accuracy, and PMD remained significant in the model.

Conclusion: Decreased L3 PMD is an independent risk predictor of SVF. Combined CT-based L1 BMD and L3 PMD can significantly improve the accuracy of predicting the risk of SVF in postmenopausal women who have suffered prior osteoporotic vertebral fractures.

Citing Articles

A Computed Tomography-Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study.

Kong S, Cho W, Park S, Choo J, Kim J, Kim S J Med Internet Res. 2024; 26:e48535.

PMID: 38995678 PMC: 11282387. DOI: 10.2196/48535.


Role of effective atomic number of paraspinal muscles in the prediction of acute vertebral fracture risk assessment: a cross-sectional case-control study.

Mai C, Liu Y, Xu D, Geng J, Wang W, Zhu K Br J Radiol. 2024; 97(1160):1437-1442.

PMID: 38833675 PMC: 11256961. DOI: 10.1093/bjr/tqae112.


The Preventive Effects of Probiotic on the Bone Loss of Mice with Ovariectomy-Mediated Osteoporosis.

Zhang Y, Cao M, Li Y, Sheng R, Zhang R, Wu M Microorganisms. 2023; 11(4).

PMID: 37110373 PMC: 10146713. DOI: 10.3390/microorganisms11040950.


Self-reported sleep characteristics are linked to type 2 diabetes in middle-aged and elderly individuals: a cross-sectional study based on NHANES.

Xia W, Yang C Ir J Med Sci. 2023; 192(6):2769-2776.

PMID: 36976264 DOI: 10.1007/s11845-023-03352-3.

References
1.
Zhu R, Kan S, Ning G, Chen L, Cao Z, Jiang Z . Which is the best treatment of osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis. Osteoporos Int. 2019; 30(2):287-298. DOI: 10.1007/s00198-018-4804-2. View

2.
Lee H, Park J, Lee I, Yi J, Kim T . Clinical, Radiographic, and Morphometric Risk Factors for Adjacent and Remote Vertebral Compression Fractures Over a Minimum Follow-up of 4 Years After Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures: Novel.... World Neurosurg. 2019; 125:e146-e157. DOI: 10.1016/j.wneu.2019.01.020. View

3.
Camacho P, Petak S, Binkley N, Diab D, Eldeiry L, Farooki A . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocr Pract. 2020; 26(Suppl 1):1-46. DOI: 10.4158/GL-2020-0524SUPPL. View

4.
Malik A, Retchin S, Phillips F, Xu W, Peters K, Yu E . Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries. Spine J. 2019; 20(4):538-546. DOI: 10.1016/j.spinee.2019.10.020. View

5.
Hinde K, Maingard J, Hirsch J, Phan K, Asadi H, Chandra R . Mortality Outcomes of Vertebral Augmentation (Vertebroplasty and/or Balloon Kyphoplasty) for Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis. Radiology. 2020; 295(1):96-103. DOI: 10.1148/radiol.2020191294. View